KYMR - Kymera Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KYMR is currently covered by 14 analysts with an average price target of $77.79. This is a potential upside of $16.94 (27.84%) from yesterday's end of day stock price of $60.85.

Kymera Therapeutics's activity chart (see below) currently has 145 price targets and 109 ratings on display. The stock rating distribution of KYMR is 83.87% BUY and 16.13% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 77.43% with an average time for these price targets to be met of 252.75 days.

Highest price target for KYMR is $80, Lowest price target is $52, average price target is $66.33.

Most recent stock forecast was given by KALPIT PATEL from B. RILEY on 23-Oct-2025. First documented stock forecast 14-Sep-2020.

Currently out of the existing stock ratings of KYMR, 26 are a BUY (83.87%), 5 are a HOLD (16.13%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$80

$21.44 (36.61%)

$60

4 days ago
(23-Oct-2025)

8/10 (80%)

$21.44 (36.61%)

183

Buy

$80

$21.44 (36.61%)

$54

11 days ago
(16-Oct-2025)

7/9 (77.78%)

$20.17 (33.71%)

96

Buy

$68

$9.44 (16.12%)

$53

28 days ago
(29-Sep-2025)

4/5 (80%)

$11.4 (20.14%)

367

Buy

$70

$11.44 (19.54%)

$60

1 months 10 days ago
(17-Sep-2025)

7/10 (70%)

$18.84 (36.83%)

81

Buy

$60

$1.44 (2.46%)

$55

1 months 11 days ago
(16-Sep-2025)

2/2 (100%)

$11.88 (24.69%)

161

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KYMR (Kymera Therapeutics) average time for price targets to be met?

On average it took 252.75 days on average for the stock forecasts to be realized with a an average price target met ratio 77.43

Which analyst has the current highest performing score on KYMR (Kymera Therapeutics) with a proven track record?

EDWARD TENTHOFF

Which analyst has the most public recommendations on KYMR (Kymera Therapeutics)?

Edward Tenthoff works at PIPER SANDLER and has 5 price targets and 4 ratings on KYMR

Which analyst is the currently most bullish on KYMR (Kymera Therapeutics)?

Geoff Meacham with highest potential upside - $21.44

Which analyst is the currently most reserved on KYMR (Kymera Therapeutics)?

Vikram Purohit with lowest potential downside - -$24.56

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?